Skip to main content
. 2014 Aug 5;9(8):e104179. doi: 10.1371/journal.pone.0104179

Figure 2. The event-free survival of patients with atherosclerotic cardiovascular disease according to treatment group (A) before and (B) after PS matching.

Figure 2

Atherosclerotic cardiovascular disease occurred more frequently in aspirin users versus non-users.